141 related articles for article (PubMed ID: 29981750)
1. Notoginsenoside R1, a unique constituent of Panax notoginseng, blinds proinflammatory monocytes to protect against cardiac hypertrophy in ApoE
Xiao J; Zhu T; Yin YZ; Sun B
Eur J Pharmacol; 2018 Aug; 833():441-450. PubMed ID: 29981750
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
3. Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling.
Sun B; Xiao J; Sun XB; Wu Y
Br J Pharmacol; 2013 Apr; 168(7):1758-70. PubMed ID: 23170834
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α mediates the effects of notoginsenoside R1 on endotoxin-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes.
Zhong L; Zhou XL; Liu YS; Wang YM; Ma F; Guo BL; Yan ZQ; Zhang QY
Mol Med Rep; 2015 Jul; 12(1):119-26. PubMed ID: 25738436
[TBL] [Abstract][Full Text] [Related]
5. Notoginsenoside R1, An Active Compound from
Gong X; Shan L; Cao S; Li K; Wu Y; Zhang Q
Am J Chin Med; 2022; 50(2):511-523. PubMed ID: 35114912
[TBL] [Abstract][Full Text] [Related]
6. miR-29c is implicated in the cardioprotective activity of Panax notoginseng saponins against isoproterenol-induced myocardial fibrogenesis.
Liu L; Ning B; Cui J; Zhang T; Chen Y
J Ethnopharmacol; 2017 Feb; 198():1-4. PubMed ID: 28017695
[TBL] [Abstract][Full Text] [Related]
7. CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis.
Xu J; Lin SC; Chen J; Miao Y; Taffet GE; Entman ML; Wang Y
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H538-47. PubMed ID: 21572015
[TBL] [Abstract][Full Text] [Related]
8. Ly6C
Schloss MJ; Hilby M; Nitz K; Guillamat Prats R; Ferraro B; Leoni G; Soehnlein O; Kessler T; He W; Luckow B; Horckmans M; Weber C; Duchene J; Steffens S
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1640-1645. PubMed ID: 28663258
[TBL] [Abstract][Full Text] [Related]
9. Notoginsenoside R1: A systematic review of its pharmacological properties.
Guo S; Xi X; Li J
Pharmazie; 2019 Nov; 74(11):641-647. PubMed ID: 31739829
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of acute myocardial infarction by saponins from flower buds of Panax notoginseng via pro-angiogenesis and anti-apoptosis.
Yang BR; Cheung KK; Zhou X; Xie RF; Cheng PP; Wu S; Zhou ZY; Tang JY; Hoi PM; Wang YH; Lee SM
J Ethnopharmacol; 2016 Apr; 181():50-8. PubMed ID: 26806572
[TBL] [Abstract][Full Text] [Related]
11. Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injury.
Wang Y; Yin Y; Liu Y; Pei C; Shen Z; Zhao S; Jia N; Huang D; Wang X; Wu Y; Shi S; He Y; Wang Z
Biomed Pharmacother; 2024 Jun; 175():116793. PubMed ID: 38776674
[TBL] [Abstract][Full Text] [Related]
12. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion.
Wan JB; Lee SM; Wang JD; Wang N; He CW; Wang YT; Kang JX
J Agric Food Chem; 2009 Aug; 57(15):6692-7. PubMed ID: 19722574
[TBL] [Abstract][Full Text] [Related]
13. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
Liu G; Wang B; Zhang J; Jiang H; Liu F
J Ethnopharmacol; 2009 Nov; 126(2):350-4. PubMed ID: 19703533
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
Fan J; Liu D; He C; Li X; He F
J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
[TBL] [Abstract][Full Text] [Related]
15. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
16. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice.
Zhang GX; Ohmori K; Nagai Y; Fujisawa Y; Nishiyama A; Abe Y; Kimura S
J Mol Cell Cardiol; 2007 Apr; 42(4):804-11. PubMed ID: 17350036
[TBL] [Abstract][Full Text] [Related]
17. Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation.
Zhang J; Ding L; Wang B; Ren G; Sun A; Deng C; Wei X; Mani S; Wang Z; Dou W
J Pharmacol Exp Ther; 2015 Feb; 352(2):315-24. PubMed ID: 25472953
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective and Anti-arrhythmic Effects of Magnesium Pretreatment Against Ischaemia/Reperfusion Injury in Isoprenaline-Induced Hypertrophic Rat Heart.
Amoni M; Kelly-Laubscher R; Petersen M; Gwanyanya A
Cardiovasc Toxicol; 2017 Jan; 17(1):49-57. PubMed ID: 26696240
[TBL] [Abstract][Full Text] [Related]
19. Preparation of a monoclonal antibody against notoginsenoside R1, a distinctive saponin from Panax notoginseng, and its application to indirect competitive ELISA.
Limsuwanchote S; Wungsintaweekul J; Yusakul G; Han JY; Sasaki-Tabata K; Tanaka H; Shoyama Y; Morimoto S
Planta Med; 2014 Mar; 80(4):337-42. PubMed ID: 24610346
[TBL] [Abstract][Full Text] [Related]
20. Implications for the role of macrophages in a model of myocardial fibrosis: CCR2(-/-) mice exhibit an M2 phenotypic shift in resident cardiac macrophages.
Falkenham A; Myers T; Wong C; Legare JF
Cardiovasc Pathol; 2016; 25(5):390-8. PubMed ID: 27327107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
